1996
DOI: 10.1155/mbd.1996.173
|View full text |Cite
|
Sign up to set email alerts
|

The Hypolipidemic Activity of Boronated Nucleosides in Male Mice and Rats

Abstract: The boronated nucleosides with varying bases and sugar moieties were shown to be potent hypolipidemic agents in rodents. The 3′– aminocynaoborane dideoxythymidine derivative caused reductions in serum cholesterol and triglyceride levels, tissue lipids, VLDL and LDL cholesterol levels while elevating HDL cholesterol levels in rodents. The agents suppressed rat hepatic acetyl CoA synthetase, HMG-CoA reductase, acyl-CoA cholesterol acyl transferase, phosphatidylate phosphohydrolase and lipoprotein lipase activiti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

1999
1999
2005
2005

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 4 publications
0
4
0
Order By: Relevance
“…The drugs did not appear to increase fecal excretion of lipids, but decreased appetite and reduced activity of ratelimiting enzymes for de novo lipid synthesis, i.e., cytoplasmic acetyl CoA synthetase, squalene synthetase, and phosphatidylate phosphohydrolase, with IC 50 values of approximately 10 -5 M [61]. The cyanoborane adduct of 3'-amino-2',3'-dideoxythymidine demonstrated potent hypolipidemic activity in CF 1 mice and Sprague-Dawley rats at 8 mg/kg/day [62]. The boronated nucleoside lowered rat serum chylomicron and VLDL cholesterol levels while increasing serum HDL cholesterol levels after 14 days.…”
Section: -Phenylpiperidine-carbomethoxyborane Tetramethylammonium Domentioning
confidence: 99%
“…The drugs did not appear to increase fecal excretion of lipids, but decreased appetite and reduced activity of ratelimiting enzymes for de novo lipid synthesis, i.e., cytoplasmic acetyl CoA synthetase, squalene synthetase, and phosphatidylate phosphohydrolase, with IC 50 values of approximately 10 -5 M [61]. The cyanoborane adduct of 3'-amino-2',3'-dideoxythymidine demonstrated potent hypolipidemic activity in CF 1 mice and Sprague-Dawley rats at 8 mg/kg/day [62]. The boronated nucleoside lowered rat serum chylomicron and VLDL cholesterol levels while increasing serum HDL cholesterol levels after 14 days.…”
Section: -Phenylpiperidine-carbomethoxyborane Tetramethylammonium Domentioning
confidence: 99%
“…after 14 days upon completion of the study. Body weights, organ weights and daily food consumption of rats were determined as previously reported [22].…”
Section: -(4'-methoxyphenacyl)-34-bis(4'-methoxyphenyl)-1h-pyrrolementioning
confidence: 99%
“…Compactin, also an HMG-CoA reductase inhibitor, has been shown to inhibit the growth of murine L929 cells [21]. Likewise, a number of amine-boranes [22][23][24][25][26][27][28], 2,3-dihydrophthalazine-l,4-diones [29], sesquiterpene lactones [30], and 1,2,4-triazolidine-3,5-diones [31] have demonstrated such crossover between cytotoxic and hypolipidemic properties. …”
Section: Introductionmentioning
confidence: 99%
“…Previously with the boron analogues of o-amino acids, i.e amine-carboxyboranes, heterocyclic amine boranes and 2'deoxynucleoside boranes other biological activities, e.g. hypolipidemic [7][8][9][10][11][12][13], antiarthritic, antiinflammatory, antiosteoporoeous [14][15][16][17][18][19] have been demonstrated in rodents. The present investigation involved the examination of boronated aromatic amino acids as potent hypolipidemic or anti-inflammatory agents in mice at 8 mg/kg, I.P.…”
Section: Introductionmentioning
confidence: 99%